CanagliflozinEuglycaemic diabetic ketoacidosis during an off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1787卷 / 1期

关键词：

D O I：

10.1007/s40278-020-73766-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：128 / 128

相关论文

共 50 条

[31] EmpagliflozinEuglycaemic diabetic ketoacidosis following off-label-use: case report
Reactions Weekly, 2022, 1917 (1) : 249 - 249
[32] BulevirtideLack of efficacy during off-label use: case report
Reactions Weekly, 2024, 2032 (1) : 99 - 99
[33] MirtazapineVisual illusions during off-label use: case report
Reactions Weekly, 2021, 1836 (1) : 504 - 504
[34] CytisiniclineLactic acidosis during off-label use: case report
Reactions Weekly, 2020, 1828 (1) : 171 - 171
[35] LevetiracetamWorsening of myoclonus during off-label use: case report
Reactions Weekly, 2018, 1693 (1) : 301 - 301
[36] AnakinraRash on back during an off-label use: case report
Reactions Weekly, 2019, 1766 (1) : 30 - 30
[37] NarsoplimabLack of efficacy during off-label use: case report
Reactions Weekly, 2023, 1940 (1) : 337 - 337
[38] PosaconazoleAcute pancreatitis during off-label use: case report
Reactions Weekly, 2020, 1824 (1) : 244 - 244
[39] IsavuconazoleNausea and vomiting during off-label use: case report
Reactions Weekly, 2019, 1735 (1) : 164 - 164
[40] RituximabNeutropenia and nausea during an off-label use: case report
Reactions Weekly, 2018, 1684 (1) : 228 - 228

← 1 2 3 4 5 →